La Jolla Pharmaceutical Company announced that effective September 30, 2020, Darryl Wellinghoff’s employment as Chief Commercial Officer of La Jolla was terminated without cause. Thomas Ouellette, Vice President of Sales and Marketing, has assumed Mr. Wellinghoff’s prior responsibilities.